Keybank National Association OH Has $74.66 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Keybank National Association OH raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.6% during the 4th quarter, HoldingsChannel reports. The fund owned 954,906 shares of the company’s stock after buying an additional 14,598 shares during the quarter. Keybank National Association OH’s holdings in GE HealthCare Technologies were worth $74,655,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. LGT Financial Advisors LLC lifted its position in GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 251 shares in the last quarter. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies in the 3rd quarter valued at $26,000. Ashton Thomas Securities LLC bought a new position in GE HealthCare Technologies during the third quarter worth about $26,000. Darwin Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies in the third quarter valued at approximately $31,000. Finally, Continuum Advisory LLC lifted its position in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Citigroup increased their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $86.45 on Tuesday. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $39.53 billion, a PE ratio of 19.97, a PEG ratio of 3.19 and a beta of 1.15. The stock’s 50 day moving average price is $86.31 and its 200-day moving average price is $86.14. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.